Daniela Ceccarelli
Research Subjects
Daniela Ceccarelli has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
- Rita R. Colwell
Maryland Pathogen Research Institute University of Maryland College Park MD USA
13 shared publications Piero Cappuccinelli
Dipartimento di Scienze Biomediche, Università di Sassari Sassari, Italy
9 shared publications- Vincent Burrus
Université de Sherbrooke
8 shared publications Dik J. Mevius
Department of Bacteriology and Epidemiology, Wageningen Bioveterinary Research, Lelystad, the Netherlands
6 shared publicationsMatteo Spagnoletti
Department of Genetics, University College London Genetics Institute, Evolution and Environment, University College London London, UK
6 shared publications- Mauro Maria Colombo
UEM, Moçambique
6 shared publications
Latest Publications
- Open Access
- 21 May 2023
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 7 (5)
Thank You to Our 2022 Peer Reviewers
Key Points: The editors thank the 2022 peer reviewers In 2022, GeoHealth benefited from 333 reviews provided by 245 of our peers A number of individuals submitted multiple reviews for GeoHealth in 2022
- 21 May 2023
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 7 (5)
Open AccessThank You to Our 2022 Peer Reviewers
Key Points: The editors thank the 2022 peer reviewers In 2022, GeoHealth benefited from 333 reviews provided by 245 of our peers A number of individuals submitted multiple reviews for GeoHealth in 2022
- Open Access
- 2 May 2022
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 6 (5)
Thank You to Our 2021 Peer Reviewers
Key Points: The editors thank the 2021 peer reviewers In 2021, GeoHealth benefited from 365 reviews provided by 241 of our peers A number of individuals submitted multiple reviews for GeoHealth in 2021
- 2 May 2022
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 6 (5)
Open AccessThank You to Our 2021 Peer Reviewers
Key Points: The editors thank the 2021 peer reviewers In 2021, GeoHealth benefited from 365 reviews provided by 241 of our peers A number of individuals submitted multiple reviews for GeoHealth in 2021
- Open Access
- 24 March 2021
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 5 (3)
Thank You to Our 2020 Peer Reviewers
Key Point: We thank our peer reviewers for all of the hard work that they do
- 24 March 2021
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 5 (3)
Open AccessThank You to Our 2020 Peer Reviewers
Key Point: We thank our peer reviewers for all of the hard work that they do
- Open Access
- 1 July 2020
- Published by Elsevier in Aquaculture
- Vol. 524
Influence of incubation time on antimicrobial susceptibility testing of pathogenic Vibrio anguillarum and Vibrio vulnificus isolated from fish
- 1 July 2020
- Published by Elsevier in Aquaculture
- Vol. 524
Open AccessInfluence of incubation time on antimicrobial susceptibility testing of pathogenic Vibrio anguillarum and Vibrio vulnificus isolated from fish
- Open Access
- 1 April 2020
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 69 (4) , 537-547
Antimicrobial resistance prevalence in commensal Escherichia coli from broilers, fattening turkeys, fattening pigs and veal calves in European countries and association with antimicrobial usage at country level
The aim of this article is to report on antimicrobial resistance (AMR) in commensal Escherichia coli from livestock from several European countries. The relationships with antimicrobial usage (AMU) at country level and harmonized indicators to cover the most relevant AMR aspects for human health in animal production were also investigated. E. coli were isolated in faeces from broilers and fattening pigs (from nine countries), and fattening turkeys and veal calves (from three countries) and screened against a fixed antimicrobial panel. AMU data were collected at farm and average treatment incidences stratified by antimicrobial class, country and livestock species were calculated. Associations between AMR and AMU at country level were analysed. Independent of animal species, the highest resistance was observed for ampicillin, sulphamethoxazole, tetracycline and trimethoprim. E. coli from broilers showed the highest resistance level for (fluoro)quinolones, and multidrug resistance peaked in broilers and fattening turkeys. Colistin resistance was observed at very low levels with the exception of fattening turkeys. High resistance to third- and fourth-generation cephalosporins was detected in broilers and fattening turkeys. The lowest levels of resistance were for meropenem, azithromycin and tigecycline (<1 %). Significant correlations between resistance and usage at country level were detected in broilers for polymyxins and aminoglycosides, and in fattening pigs for cephalosporins, amphenicols, fluoroquinolones and polymyxins. None of the correlations observed between AMR and AMU were statistically significant for fattening turkey and veal calves. The strength of the analysis performed here is the correlation of aggregated data from the same farms at country level for both AMU and AMR within antimicrobial classes.
- 1 April 2020
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 69 (4) , 537-547
Open AccessAntimicrobial resistance prevalence in commensal Escherichia coli from broilers, fattening turkeys, fattening pigs and veal calves in European countries and association with antimicrobial usage at country level
The aim of this article is to report on antimicrobial resistance (AMR) in commensal Escherichia coli from livestock from several European countries. The relationships with antimicrobial usage (AMU) at country level and harmonized indicators to cover the most relevant AMR aspects for human health in animal production were also investigated. E. coli were isolated in faeces from broilers and fattening pigs (from nine countries), and fattening turkeys and veal calves (from three countries) and screened against a fixed antimicrobial panel. AMU data were collected at farm and average treatment incidences stratified by antimicrobial class, country and livestock species were calculated. Associations between AMR and AMU at country level were analysed. Independent of animal species, the highest resistance was observed for ampicillin, sulphamethoxazole, tetracycline and trimethoprim. E. coli from broilers showed the highest resistance level for (fluoro)quinolones, and multidrug resistance peaked in broilers and fattening turkeys. Colistin resistance was observed at very low levels with the exception of fattening turkeys. High resistance to third- and fourth-generation cephalosporins was detected in broilers and fattening turkeys. The lowest levels of resistance were for meropenem, azithromycin and tigecycline (<1 %). Significant correlations between resistance and usage at country level were detected in broilers for polymyxins and aminoglycosides, and in fattening pigs for cephalosporins, amphenicols, fluoroquinolones and polymyxins. None of the correlations observed between AMR and AMU were statistically significant for fattening turkey and veal calves. The strength of the analysis performed here is the correlation of aggregated data from the same farms at country level for both AMU and AMR within antimicrobial classes.
- Open Access
- 13 March 2020
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 4 (3)
Thank You to Our 2019 Peer Reviewers
Key Points: The editors thank the 2019 peer reviewers
- 13 March 2020
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 4 (3)
Open AccessThank You to Our 2019 Peer Reviewers
Key Points: The editors thank the 2019 peer reviewers
- Open Access
- 16 February 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (2) , 87
Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
Companion animals have been described as potential reservoirs of antimicrobial resistance (AMR), however data remain scarce. Therefore, the objectives were to describe antimicrobial usage (AMU) in dogs and cats in three European countries (Belgium, Italy, and The Netherlands) and to investigate phenotypic AMR. A questionnaire and one fecal sample per animal (n = 303) were collected over one year and AMU was quantified using treatment incidence (TI). Phenotypic resistance profiles of 282 Escherichia coli isolates were determined. Nineteen percent of the animals received at least one antimicrobial treatment six months preceding sampling. On average, cats and dogs were treated with a standard daily dose of antimicrobials for 1.8 and 3.3 days over one year, respectively. The most frequently used antimicrobial was amoxicillin-clavulanate (27%). Broad-spectrum antimicrobials and critically important antimicrobials for human medicine represented 83% and 71% of the total number of treatments, respectively. Resistance of E. coli to at least one antimicrobial agent was found in 27% of the isolates. The most common resistance was to ampicillin (18%). Thirteen percent was identified as multidrug resistant isolates. No association between AMU and AMR was found in the investigated samples. The issue to address, regarding AMU in companion animal, lies within the quality of use, not the quantity. Especially from a One-Health perspective, companion animals might be a source of transmission of resistance genes and/or resistant bacteria to humans.
- 16 February 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (2) , 87
Open AccessAntimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
Companion animals have been described as potential reservoirs of antimicrobial resistance (AMR), however data remain scarce. Therefore, the objectives were to describe antimicrobial usage (AMU) in dogs and cats in three European countries (Belgium, Italy, and The Netherlands) and to investigate phenotypic AMR. A questionnaire and one fecal sample per animal (n = 303) were collected over one year and AMU was quantified using treatment incidence (TI). Phenotypic resistance profiles of 282 Escherichia coli isolates were determined. Nineteen percent of the animals received at least one antimicrobial treatment six months preceding sampling. On average, cats and dogs were treated with a standard daily dose of antimicrobials for 1.8 and 3.3 days over one year, respectively. The most frequently used antimicrobial was amoxicillin-clavulanate (27%). Broad-spectrum antimicrobials and critically important antimicrobials for human medicine represented 83% and 71% of the total number of treatments, respectively. Resistance of E. coli to at least one antimicrobial agent was found in 27% of the isolates. The most common resistance was to ampicillin (18%). Thirteen percent was identified as multidrug resistant isolates. No association between AMU and AMR was found in the investigated samples. The issue to address, regarding AMU in companion animal, lies within the quality of use, not the quantity. Especially from a One-Health perspective, companion animals might be a source of transmission of resistance genes and/or resistant bacteria to humans.
- Open Access
- 1 December 2019
- Published by Elsevier in Veterinary Microbiology
- Vol. 239, 108446
Effect of challenge dose of plasmid-mediated extended-spectrum β-lactamase and AmpC β-lactamase producing Escherichia coli on time-until-colonization and level of excretion in young broilers
- 1 December 2019
- Published by Elsevier in Veterinary Microbiology
- Vol. 239, 108446
Open AccessEffect of challenge dose of plasmid-mediated extended-spectrum β-lactamase and AmpC β-lactamase producing Escherichia coli on time-until-colonization and level of excretion in young broilers
- Open Access
- 18 April 2019
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 3 (4) , 82-83
Thank You to Our 2018 Peer Reviewers
Public trust in science, effective science communication, and rapid and constructive response to authors about their submissions are of paramount importance to the scientific enterprise and indeed to society itself. This is really at the heart of peer review—providing thoughtful insights into both the scientific quality and importance of work, and also how it is communicated to other scientists and increasingly to a broader audience. Very few opportunities exist to acknowledge the mostly anonymous process of peer review, especially given the huge increase in review requests and the relatively mechanical nature of online reviewing platforms. We continue to be humbled by the time, effort, and careful insights that our colleagues share with each other through the process of peer review. In 2018, GeoHealth benefited from more than 83 reviews provided by 53 of our peers for papers submitted to the journal. Thank you all for your awesome efforts toward advancing geohealth now and for the future.
- 18 April 2019
- Published by American Geophysical Union (AGU) in GeoHealth
- Vol. 3 (4) , 82-83
Open AccessThank You to Our 2018 Peer Reviewers
Public trust in science, effective science communication, and rapid and constructive response to authors about their submissions are of paramount importance to the scientific enterprise and indeed to society itself. This is really at the heart of peer review—providing thoughtful insights into both the scientific quality and importance of work, and also how it is communicated to other scientists and increasingly to a broader audience. Very few opportunities exist to acknowledge the mostly anonymous process of peer review, especially given the huge increase in review requests and the relatively mechanical nature of online reviewing platforms. We continue to be humbled by the time, effort, and careful insights that our colleagues share with each other through the process of peer review. In 2018, GeoHealth benefited from more than 83 reviews provided by 53 of our peers for papers submitted to the journal. Thank you all for your awesome efforts toward advancing geohealth now and for the future.
- Open Access
- 3 March 2019
- Published by Wiley in Microbiologyopen
- Vol. 8 (9) , e00821
Patterns of community assembly in the developing chicken microbiome reveal rapid primary succession
The fine‐scale temporal dynamics of the chicken gut microbiome are unexplored, but thought to be critical for chicken health and productivity. Here, we monitored the fecal microbiome of healthy chickens on days 1–7, 10, 14, 21, 28, and 35 after hatching, and performed 16S rRNA amplicon sequencing in order to obtain a high‐resolution census of the fecal microbiome over time. In the period studied, the fecal microbiomes of the developing chickens showed a linear‐log increase in community richness and consistent shifts in community composition. Three successional stages were detected: the first stage was dominated by vertically transmitted or rapidly colonizing taxa including Streptococcus and Escherichia/Shigella; in the second stage beginning on day 4, these taxa were displaced by rapid‐growing taxa including Lachnospiraceae and Ruminococcus‐like species variants; and in the third stage, starting on day 10, slow‐growing, specialist taxa including Candidatus Arthrobacter and Romboutsia were detected. The patterns of displacement and the previously reported ecological characteristics of many of the dominant taxa observed suggest that resource competition plays an important role in regulating successional dynamics in the developing chicken gut. We propose that the boundaries between successional stages (3–4 and 14–21 days after hatching) may be optimal times for microbiome interventions.
- 3 March 2019
- Published by Wiley in Microbiologyopen
- Vol. 8 (9) , e00821
Open AccessPatterns of community assembly in the developing chicken microbiome reveal rapid primary succession
The fine‐scale temporal dynamics of the chicken gut microbiome are unexplored, but thought to be critical for chicken health and productivity. Here, we monitored the fecal microbiome of healthy chickens on days 1–7, 10, 14, 21, 28, and 35 after hatching, and performed 16S rRNA amplicon sequencing in order to obtain a high‐resolution census of the fecal microbiome over time. In the period studied, the fecal microbiomes of the developing chickens showed a linear‐log increase in community richness and consistent shifts in community composition. Three successional stages were detected: the first stage was dominated by vertically transmitted or rapidly colonizing taxa including Streptococcus and Escherichia/Shigella; in the second stage beginning on day 4, these taxa were displaced by rapid‐growing taxa including Lachnospiraceae and Ruminococcus‐like species variants; and in the third stage, starting on day 10, slow‐growing, specialist taxa including Candidatus Arthrobacter and Romboutsia were detected. The patterns of displacement and the previously reported ecological characteristics of many of the dominant taxa observed suggest that resource competition plays an important role in regulating successional dynamics in the developing chicken gut. We propose that the boundaries between successional stages (3–4 and 14–21 days after hatching) may be optimal times for microbiome interventions.